Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Irulecrapon Nov 22, 2010 12:15pm
454 Views
Post# 17739377

Experts who have talked about QEI

Experts who have talked about QEI

Experts who have talked about Quetzal Energy

Comment 0.190 Eric Nuttall Has done very well. Been increasing on 2 primary themes. 1) Junior Colombian names have been very strong recently and 2) appear to have made an oil discovery where net oil play was significantly more than expected. 2010-10-27
SPECULATIVE BUY 0.170 Peter Hodson You are in the zone of testing right now. Have an oil well and put out a press release this week. Until they come out with a number you don’t know. If they hit this well you could see good things. 2010-10-19
HOLD 0.145 Peter Imhof Some hiccups trying to bring a well into production in Guatemala. True upside in this story is in Colombia. Had about 110 feet of net pay in Colombia before having to give back their loaned rig. Bringing another rig in and will be testing in a couple of weeks. Arranged another $9.5 million of financing. Still cheap. 2010-09-23
BUY 0.140 Peter Imhof Still waiting for results from Guatemala. Spudded a well in Colombia that should be giving some news in the next 6 weeks or so. Huge targets. All the companies around them have been hitting 5000-10,000 BOE's and it would be a game changer for them if they could hit any of these. Speculative. 2010-07-16
TOP PICK 0.185 Peter Imhof Gas play in Guatemala and Colombia. Have a lot of land blocks near where Petrominerales (PMG-T) hit. Just drilled a well with a fairly large target in Guatemala and found oil at a much higher area than expected. Cased the well and we'll hear more next week. Highly speculative.
Bullboard Posts